Effect of Probiotic Lozenges on Halitosis in Patients With Chronic

Status Not yet recruiting

Clinical Trial Summary

The purpose of this study is to determine whether Lactobacillus reuteri-containing lozenges (Prodentis) are effective in treatment of halitosis in patients with chronic periodontitis.

Clinical Trial Description

Bad breath (oral malodor, lat. halitosis) is amongst most common patients' complaints in the dental office. Ironically, available literature and research done on this topic thus far are relatively scarce. Oral malodor is most commonly caused by oral bacteria (87%), yet it can also be sourced from ear, nose and throat region and in a small percentage from distant parts of the body or is of unknown origin. Periodontal pathogens and other Gram(-) anaerobic microorganisms such as Porphyromonas gingivalis, Treponema denticola, Prevotella intermedia, Fusobacterium nucleatum, Enterobacter cloacae, Prevotella loescheii and Porphyromonas endodontalis are regarded as producers of malodorous gases. Namely, these bacterial species and periodontal pathogens particularly produce so called volatile sulfur compounds (VSC) which give mouth air its malodorness. Methylmercaptan, hydrogen sulfide and dimethyl sulfide are waste products of bacterial metabolism, specifically degradation of sulfur-, methionine- and cysteine-containing aminoacids. Offensive smells also stem from other compounds which do not contain sulfur, diamines and polyamines such as cadaverine, putrescine and skatole.

Probiotics are defined as living microorganisms which are considered to have beneficial health effect on their host when consumed in adequate amount. Regarding their advantageous role in periodontal disease, inhibition of specific periodontal pathogens and alteration of host immune response through multifactorial causes are thought to be their main working mechanisms. Reuterin and reutericyclin are two bacteriocins produced by Lactobacillus reuteri that inhibit growth of pathogenic bacteria, while bacterium also exhibits strong capacity of host tissue adherence and subsequent competition with pathogens.

Based on this data, research on efficacy of probiotic lozenges on halitosis in patients with chronic periodontitis. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator)

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02789436
Study type	Interventional
Source	University of Zagreb
Contact	Larisa Music, DMD
Email	lmusic@sfzg.hr
Status	Not yet recruiting
Phase	Phase 4
Start date	June 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04279106` - Effect of Single Rinsing With Three Different Types of Mouthwash on VSC Levels in Morning Breath	N/A
Completed	`NCT05413382` - Effect of an Investigational Lozenge (Biofresh® 4plus) Versus Placebo Control on Oral Malodor (Intra-Oral Halitosis)	N/A
Completed	`NCT04914208` - Effect of Wearing Face Masks on Salivary Parameters and Halitosis	N/A
Completed	`NCT05524948` - A Clinical Study to Examine the Effects of an Experimental Toothpaste Compared to a Regular Fluoride Toothpaste on Breath Odor in a Population With Gingivitis	N/A
Completed	`NCT02113137` - Oral Hygiene Procedures on Reduction of Oral Malodor	Phase 4
Completed	`NCT02689297` - Three Different Oral Hygiene Regimes on Three Volatile Sulfur Compounds	Phase 4
Completed	`NCT01046812` - Halitosis Devised Questionnaire Evaluating a New Treatment	N/A
Withdrawn	`NCT02665780` - Assessing the Effect of Periodontal Debridement, Tongue Cleaning and Mouth Rinsing for the Treatment of Oral Malodour	N/A
Completed	`NCT01948349` - Impact of Bracket Design and Oral Hygiene Maintenance on Halitosis in the Orthodontic Patient	N/A
Recruiting	`NCT02007993` - Photodynamic Therapy in Adolescents Halitosis	N/A
Completed	`NCT01269957` - Halitosis and Mouth Breathing in Children	N/A
Completed	`NCT04632004` - Questionnaire Regarding the Effect of Wearing Face Masks on Oral Health	N/A
Completed	`NCT04998617` - Effects of Curcumin-containing Toothpaste on Dental Biofilm and Associated Oral Halitosis	N/A
Completed	`NCT01139073` - A New Portable Monitor for Measuring Odorous Compounds in Oral, Exhaled and Nasal Air	N/A
Not yet recruiting	`NCT00875927` - Effects of Breezy Candy on Halitosis	Phase 1/Phase 2
Completed	`NCT03196648` - Randomized Trial of a Gum Health Formulation	N/A
Recruiting	`NCT03346460` - Effect of Photodymamic Therapy With Urucum and LED in the Reduction of Halitosis	Phase 2
Completed	`NCT03468595` - Clinical Evaluation of Some Local Antimicrobial Agents' Adjunctive Effects On Periodontal Parameters and Halitosis	N/A
Completed	`NCT02794766` - Inulin and S. Salivarius Reduce Halitosis	Phase 2
Completed	`NCT02628938` - Effect of Miswak and Miswak Extract on Oral Malodor	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effect of Probiotic Lozenges on Halitosis in Patients With Chronic Periodontitis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms